chartexchange

OMER
Omeros Corporation
stockNASDAQ

At CloseNov 3, 2026 3:59:57 PM EST
18.27USD+2.468%(+0.44)886,831
Loading…
Loading…
Healthcare
Biotechnology
CEO
Gregory Demopulos
HQ
Seattle, WA, USA
Previous Close
$17.83
Beta
1.75
52-Week High
$21.24 2026-09-22
52-Week Low
$6.24 2025-11-13
SMA 50
$18.49
SMA 200
$13.51
Avg. Vol 10D
1.05M
Avg. Vol 30D
1.23M
Avg. Vol 90D
1.73M
Relative Vol
0.39
69.29M
11,428,767
0.4700%
2,200,000
18,060
Nov 12, 2026 (8d)
OMER Profile

omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.

OMER Performance
PeriodPriceDateChangeBeta
1W17.492026-10-27+4.26%2.624
1M18.612026-10-02-2.02%2.279
3M12.562026-08-03+45.18%2.792
6M14.912026-05-04+22.30%1.812
1Y7.172025-11-03+154.32%1.747
2Y4.252024-11-04+329.06%—
5Y7.452021-11-03+144.76%1.587
OMER Stock Summary

Omeros Corporation (NASDAQ:OMER) stock price today is $18.24, and today's volume is 478,057. OMER is up 2.271% today. The 30 day average volume is 1.23M. OMER market cap is $1.32B with 72.39M shares outstanding.